Sustained effects of a protein and lipid preload on glucose tolerance in type 2 diabetes patients - 22/09/16
, E. Filice a, S. Baldi a, S. Frascerra a, A. Mari b, A. Natali a
Bienvenido a EM-consulte, la referencia de los profesionales de la salud.
Artículo gratuito.
Conéctese para beneficiarse!
Abstract |
Background |
Small amounts of nutrients given as a ‘preload’ can reduce post-meal hyperglycaemic peaks in type 2 diabetes (T2D) patients by activating a number of mechanisms involved in glucose homoeostasis. This study was undertaken to ascertain whether this positive effect extends to the late absorptive phase and to identify the main mechanisms involved.
Material and methods |
Eight well-controlled T2D patients, aged 40–70 years, were randomized to consume a ‘preload’ of either water or non-glucidic nutrients (50g of Parmesan cheese, one boiled egg) 30min before a 300-min oral glucose tolerance test.
Results |
After the nutrient preload, significant reductions were observed in peak glucose (−49%; P<0.02), total plasma glucose (iAUC: −28%; P<0.03), exogenous glucose (iAUC: −30%; P<0.03) and insulin clearance (−28%; P<0.04), with enhancement of insulin secretion (iAUC: +22%; P<0.003). These effects were associated with higher plasma levels of GLP-1 (iAUC: +463%; P<0.002), GIP (iAUC: +152%; P<0.0003) and glucagon (iAUC: +144%; P<0.0002).
Conclusion |
In T2D patients, a protein and lipid preload improves glucose tolerance throughout the whole post-absorptive phase mainly by reducing the appearance of oral glucose, and improving both beta-cell function and insulin bioavailability.
El texto completo de este artículo está disponible en PDF.Abbreviations : FFM, FPG, FPI, GIP, GLP-1, iAUC, ISR, ISR@FPG, OGIS, T2D
Keywords : Beta-cell function, Glucose absorption, Insulin secretion in vivo, Nutrient preload, Type 2 diabetes
Esquema
| ☆ | Trial registration: ClinicalTrials.gov NCT02477761. |
Vol 42 - N° 4
P. 242-248 - septembre 2016 Regresar al número
Artículo precedente
- Effects of probiotic supplementation on glycaemic control and lipid profiles in gestational diabetes: A randomized, double-blind, placebo-controlled trial
- M. Karamali, F. Dadkhah, M. Sadrkhanlou, M. Jamilian, S. Ahmadi, M. Tajabadi-Ebrahimi, P. Jafari, Z. Asemi
- Effect of insulin analogues on frequency of non-severe hypoglycaemia in patients with type 1 diabetes prone to severe hypoglycaemia: The HypoAna trial
- R.M. Agesen, P.L. Kristensen, H. Beck-Nielsen, K. Nørgaard, H. Perrild, J.S. Christiansen, T. Jensen, P. Hougaard, H.H. Parving, B. Thorsteinsson, L. Tarnow, U. Pedersen-Bjergaard
Bienvenido a EM-consulte, la referencia de los profesionales de la salud.